{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:42:44Z","timestamp":1767840164027,"version":"3.49.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T00:00:00Z","timestamp":1688601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Colorectal cancer (CRC) is one of the most common solid malignant burdens worldwide. Cancer immunology and immunotherapy have become fundamental areas in CRC research and treatment. Currently, the method of generating Immune-Related Gene Prognostic Indices (IRGPIs) has been found to predict patient prognosis as an immune-related prognostic biomarker in a variety of tumors. However, their role in patients with CRC remains mostly unknown. Therefore, we aimed to establish an IRGPI for prognosis evaluation in CRC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>RNA-sequencing data and clinical information of CRC patients were retrieved from The Cancer Genome Atlas (TCGA) and The Gene Expression Omnibus (GEO) databases as training and validation sets, respectively. Immune-related gene data was obtained from the <jats:italic>ImmPort<\/jats:italic> and <jats:italic>InnateDB<\/jats:italic> databases. The weighted gene co-expression network analysis (WGCNA) was used to identify hub immune-related genes. An IRGPI was then constructed using Cox regression methods. Based on the median risk score of IRGPI, patients could be divided into high-risk and low-risk groups. To further investigate the immunologic differences, Gene set variation analysis (GSVA) studies were conducted. In addition, immune cell infiltration and related functional analysis were used to identify the differential immune cell subsets and related functional pathways.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We identified 49 immune-related genes associated with the prognosis of CRC, 17 of which were selected for an IRGPI. The IRGPI model significantly differentiates the survival rates of CRC patients in the different groups. The IRGPI as an independent prognostic factor significantly correlates with clinico-pathological factors such as age and tumor stage. Furthermore, we developed a nomogram to improve the clinical utility of the IRGPI score. Immuno-correlation analysis in different IRGPI groups revealed distinct immune cell infiltration (CD4<jats:sup>+<\/jats:sup> T cells resting memory) and associated pathways (macrophages, Type I IFNs responses, iDCs.), providing new insights into the tumor microenvironment. At last, drug sensitivity analysis revealed that the high-risk IRGPI group was sensitive to 11 and resistant to 15 drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study established a promising immune-related risk model for predicting survival in CRC patients. This could help to better understand the correlation between immunity and the prognosis of CRC providing a new perspective for personalized treatment of CRC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1156488","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T14:38:25Z","timestamp":1688654305000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer"],"prefix":"10.3389","volume":"14","author":[{"given":"Chao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josefine","family":"Schardey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor V.","family":"Ehrlich-Treuenst\u00e4tt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandr V.","family":"Bazhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21772","article-title":"Colorectal cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1001\/jama.2016.13849","article-title":"Colorectal cancer screening","volume":"316","author":"Pinsky","year":"2016","journal-title":"JAMA"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24760","article-title":"Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates","volume":"116","author":"Edwards","year":"2010","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34185","article-title":"Top advances of the year in colorectal cancer","volume":"128","author":"Saltz","year":"2022","journal-title":"Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-Small-Cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104621","article-title":"Ipilimumab plus dacarbazine for previously untreated metastatic melanoma","volume":"364","author":"Robert","year":"2011","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1718095","article-title":"Pembrolizumab for the treatment of colorectal cancer","volume":"20","author":"Coupez","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2017.0016","article-title":"Response to PD-1 blockade in microsatellite stable metastatic colorectal cancer harboring a POLE mutation","volume":"15","author":"Gong","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"B13","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.esmoop.2021.100336","article-title":"Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers","volume":"7","author":"Palmeri","year":"2022","journal-title":"ESMO Open"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.845093","article-title":"Development of a novel immune-related gene prognostic index for breast cancer","volume":"13","author":"Yao","year":"2022","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-22-494","article-title":"A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments","volume":"14","author":"Wang","year":"2022","journal-title":"J Thorac Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an r package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010037","article-title":"Molecular signature of subtypes of non-small-cell lung cancer by Large-scale transcriptional profiling: identification of key modules and genes by weighted gene Co-expression network analysis (WGCNA)","volume":"12","author":"Niemira","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/sim.6079","article-title":"Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality","volume":"33","author":"Lorent","year":"2014","journal-title":"Stat Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02743-0","article-title":"An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma","volume":"70","author":"Dai","year":"2021","journal-title":"Cancer Immunol Immunother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1022808","article-title":"IL-7: a promising adjuvant ensuring effective T cell responses and memory in combination with cancer vaccines","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1025330","article-title":"Ensemble deep learning enhanced with self-attention for predicting immunotherapeutic responses to cancers","volume":"13","author":"Jin","year":"2022","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1145797","article-title":"Identification of copper metabolism-related subtypes and establishment of the prognostic model in ovarian cancer","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.975859","article-title":"Molecular characteristics, clinical significance, and cancer immune interactions of cuproptosis and ferroptosis-associated genes in colorectal cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1090040","article-title":"Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and parkinson's disease","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1089410","article-title":"Exosomes: a potential tool for immunotherapy of ovarian cancer","volume":"13","author":"Gong","year":"2022","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.839901","article-title":"An immune-related gene pair index predicts clinical response and survival outcome of immune checkpoint inhibitors in melanoma","volume":"13","author":"Yan","year":"2022","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102979","article-title":"Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer","volume":"12","author":"Lin","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.944286","article-title":"Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma","volume":"13","author":"Liang","year":"2022","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.2644","article-title":"ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer","volume":"24","author":"Locker","year":"2006","journal-title":"J Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17706-X","article-title":"Colorectal cancer","volume":"365","author":"Weitz","year":"2005","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/jjco\/hyy142","article-title":"New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer","volume":"49","author":"Hattori","year":"2019","journal-title":"Jpn J Clin Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2014.02.001","article-title":"Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal","volume":"41","author":"Seftor","year":"2014","journal-title":"Semin Oncol"},{"key":"B37","article-title":"Investigation of the mek-MAP kinase-rsk pathway in human breast cancer","volume":"19","author":"Salh","year":"1999","journal-title":"Anticancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40364-022-00396-y","article-title":"ZG16 promotes T-cell mediated immunity through direct binding to PD-L1 in colon cancer","volume":"10","author":"Meng","year":"2022","journal-title":"biomark Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.07.003","article-title":"Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation","volume":"24","author":"Corbet","year":"2016","journal-title":"Cell Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13491","article-title":"LINC02499, a novel liver-specific long non-coding RNA with potential diagnostic and prognostic value, inhibits hepatocellular carcinoma cell proliferation, migration, and invasion","volume":"50","author":"Ma","year":"2020","journal-title":"Hepatol Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065767","article-title":"The gut microbiome, microsatellite status and the response to immunotherapy in colorectal cancer","volume":"24","author":"Sillo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12920-014-0064-y","article-title":"FLAGS, frequently mutated genes in public exomes","volume":"7","author":"Shyr","year":"2014","journal-title":"BMC Med Genomics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-1-4419-1145-2_8","article-title":"APC and its modifiers in colon cancer","volume":"656","author":"Kwong","year":"2009","journal-title":"Adv Exp Med Biol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djw332","article-title":"Multiple roles of APC and its therapeutic implications in colorectal cancer","volume":"109","author":"Zhang","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00148","article-title":"Friend or foe: prognostic and immunotherapy roles of BTLA in colorectal cancer","volume":"7","author":"Song","year":"2020","journal-title":"Front Mol Biosci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2085432","DOI":"10.1080\/2162402X.2022.2085432","article-title":"Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32658","article-title":"NAD(+) salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity","author":"Guo","year":"2022","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-2187-6-7","article-title":"Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells","volume":"6","author":"Nautiyal","year":"2011","journal-title":"J Mol Signal"},{"key":"B49","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41598-017-00839-9","article-title":"Leucovorin enhances the anti-cancer effect of bortezomib in colorectal cancer cells","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-01147-2","article-title":"Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +\/- binimetinib or alpelisib","volume":"124","author":"Huijberts","year":"2021","journal-title":"Br J Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1156488\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T14:38:31Z","timestamp":1688654311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1156488\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2023.1156488"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1156488","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]},"article-number":"1156488"}}